STAT3 activation has been reported to contribute to MM progression both directly, by upregulating survival and anti-apoptotic target genes, as well as indirectly by activating myeloid-derived suppressor-cells (MDSCs) in the bone marrow microenvironment, which facilitates tumor progression [120,121]. This evidence concerns the gene STAT3 and Miyoshi myopathy.